IFX monitoring





RIDA®QUICK IFX Monitoring

  • Quality, speed, convenience – all in one package!
  • Fast and convenient implementation
  • All R-biopharm rapid tests pass QMCD quality control

R-biopharm's rapid test is designed for the quantitative determination of infliximab (IFX, Remicade®) and the biosimilars Remsima® and Inflectra® in human serum and plasma.

Allows quantitative determination of infliximab levels within 20 minutes.

In the package:
25 cartridges






Ask for more information!


Liis Mäekivi, Product Manager

Phone: +372 5103961